London will establish the world’s first solar bridge
 |
One of the world’s largest solar bridges will be built on the Thames. The bridge will be converted from the Blackfriars Railway Bridge in central London and will consist of more than 6,000 square meters of photovoltaic materials. The number of photovoltaic panels will exceed 4,400 and is expected to generate approximately 900,000 kilowatts per year. At the time of the power, the bridge was built by British company Solar Century. The bridge was first established in 1886. The solar technology will rejuvenate the 100-year-old bridge. Apart from the solar panels manufactured by Sanyo Electric, the bridge will also include a rainwater collection system and natural solar lighting.
Maxacalcitol (22-Oxacalcitriol) is non-calcemic vitamin D3 analog and ligand of VDR-like receptors. IC50 value: Target: Maxacalcitol (22-Oxacalcitriol)suppresses parathyroid hormone (PTH) mRNA expression in vitro and in vivo. Maxacalcitol exhibits similar effects to calcitriol in osteoblast-like cells. Maxacalcitol(22-Oxacalcitriol) inhibits tumor growth of osteosarcoma in vitro in combination with all-trans retinoic acid
Eldecalcitol (ED-71; 2.beta.-(3-Hydroxypropoxy)-1.alpha.,25-dihydroxyvitamin D3) is an analog of 1,25-dihydroxyvitamin D3 that improves bone mineral density. IC50 value: Target: Vd analog Eldecalcitol (ED-71; 2.beta.-(3-Hydroxypropoxy)-1.alpha.,25-dihydroxyvitamin D3) is more efficacious than alfacalcidol in preventing vertebral and wrist fractures in osteoporotic patients with vitamin D sufficiency, with a safety profile similar to alfacalcidol
Calcitriol Series,Eldecalcitol Intermediate,Ring A Cas 239100-35-7,Cas 103909-75-7 In Stock
Jinan Meigao Biopharmaceutical Technology Co., Ltd. , http://www.meigaobiopharma.com